Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency

The transdermal delivery system (TDS) is able to obtain a systemic therapeutic effect by administration through the skin, which has low side effects and is able to maintain a sustained blood concentration. However, due to the barrier presented by the stratum corneum, numerous drugs have poor percuta...

Descripción completa

Detalles Bibliográficos
Autores principales: CHEN, BIN, LIU, DA-LIE, PAN, WEN-YAN, YANG, XIAO-HUI, SHOU, JIA-BAO, WU, JU-HUA, MAO, QING-LONG, WANG, JIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094769/
https://www.ncbi.nlm.nih.gov/pubmed/24858729
http://dx.doi.org/10.3892/mmr.2014.2251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094769/
https://www.ncbi.nlm.nih.gov/pubmed/24858729
http://dx.doi.org/10.3892/mmr.2014.2251

Ejemplares similares